Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Blood Pressure, High

dabigatran has been researched along with Blood Pressure, High in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's16 (57.14)24.3611
2020's12 (42.86)2.80

Authors

AuthorsStudies
Barnett-Griness, O; Gronich, N; Kotler, A; Saliba, W; Stein, N1
Bahit, MC; Brainin, M; Brueckmann, M; Cronin, L; Diener, HC; Easton, JD; Granger, CB; Grauer, C; Kleine, E; Lopes, RD; Lyrer, P; Meyerhoff, J; Sacco, RL; Segura, T; Wachter, R1
Alioğlu, E; Altın, C; Bilgin, N; Çetin, N; Dalgıç, O; Ekmekçi, C; Kocabaş, U; Özpelit, ME; Pekel, N; Topaloğlu, C; Tülüce, K; Tunçer, E; Türk, UÖ; Türkoğlu, Eİ; Yavuz, V; Yüksel, K1
Bielecka, B; Gorczyca-Głowacka, I; Wożakowska-Kapłon, B1
Chen, X; Dai, H; Du, X; Gu, P; Guan, C; Huang, N; Huang, X; Li, R; Lin, X; Liu, X; Liu, Y; Lv, M; Wu, T; Xu, W; Zhang, J; Zhang, M; Zhang, W; Zheng, Q; Zhu, Z1
Aimo, A; De Caterina, R; Petricciuolo, S1
Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I1
Co, COC; Domingo, AMC; Iboleon-Dy, MAM; Ilano, KCS; Laxamana, LC; Macrohon-Valdez, MCZ; Mojica, CV; Yu, JRT1
Bao, H; Cheng, X; Hu, L; Li, M; Wang, T; Yu, Y; Zhou, W; Zhu, L1
Chukhliaev, PV; Garbuzov, AA; Khavkina, DA; Ploskireva, AA; Ruzhentsova, TA1
Böhm, M; Brueckmann, M; Connolly, S; Eikelboom, JW; Ewen, S; Ezekowitz, M; Millenaar, D; Schumacher, H; Slawik, J; Ukena, C; Wallentin, L; Yusuf, S1
Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C1
Bar, A; Chlopicki, S; Enggaard, C; Hansen, PBL; Jasztal, A; Jensen, B; Kieronska-Rudek, A; Kij, A; Marczyk, B; Mateuszuk, L; Matyjaszczyk-Gwarda, K; Proniewski, B; Przyborowski, K; Tworzydlo, A; Walczak, M1
Agosti, S; Casalino, L; Rocci, E; Rota, E; Zaccone, G1
Collings, SL; Evans, D; Hack, G; Johnson, ME; Lefèvre, C; Maguire, A; Stynes, G1
Hart, A; Shroff, GR; Stoecker, R1
Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T1
Ahmad, Y; Lip, GY1
Barrios, V; Escobar, C1
Diener, HC1
González-Rico, MA; Juan-García, I; Miguel-Carrasco, A; Puchades-Montesa, MJ; Ramos-Tomás, C; Ribés-Cruz, JJ; Solís-Salguero, MA; Tejedor-Alonso, S; Tomás-Simó, P; Torregrosa-Maicas, I; Zambrano-Esteves, P1
Okada, Y; Yasaka, M1
Bettex, D; Bosshart, M; Brand, B; Schlicker, A; Spahn, DR; Stein, P1
Berthold, C; Boecher-Schwarz, H; Dooms, G; Gunness, VR; Hana, A; Hertel, F; Koy, J; Matgé, G; Standhardt, H1
Meesmann, M; Scheppach, W1
Brueckmann, M; Clemens, A; Connolly, SJ; Ezekowitz, MD; Nagarakanti, R; Noack, H; Reilly, P; Wallentin, L; Yusuf, S1
Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A1
Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS1

Reviews

4 review(s) available for dabigatran and Blood Pressure, High

ArticleYear
[Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease].
    Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:1

    Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Diabetes Complications; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Off-Label Use; Prevalence; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Sex Factors; Sleep Apnea, Obstructive; Stroke; Thiazoles; Thromboembolism

2020
Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018, Volume: 72, Issue:5

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cyclophosphamide; Dabigatran; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Male; Multimorbidity; Obesity; Prognosis; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk Assessment; Rivaroxaban; Thromboembolism

2018
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Contributions to nephrology, 2013, Volume: 179

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Disease Management; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Intracranial Embolism; Male; Morpholines; Patient Selection; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Warfarin

2013
NOAC and intracerebral bleeding--presentation of four cases and review of the literature.
    Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg, 2014, Issue:1

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Female; Humans; Hypertension; Male; Morpholines; Rivaroxaban; Thiophenes

2014

Trials

2 trial(s) available for dabigatran and Blood Pressure, High

ArticleYear
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation, 2021, 11-30, Volume: 144, Issue:22

    Topics: Administration, Oral; Age Factors; Aged; Aspirin; Atrial Fibrillation; Body Mass Index; Dabigatran; Double-Blind Method; Embolic Stroke; Female; Humans; Hypertension; Male; Middle Aged; Models, Cardiovascular; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Recurrence; Risk Factors

2021
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).
    The American journal of cardiology, 2015, Oct-15, Volume: 116, Issue:8

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Stroke; Treatment Outcome; Warfarin

2015

Other Studies

22 other study(ies) available for dabigatran and Blood Pressure, High

ArticleYear
Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart (British Cardiac Society), 2022, Volume: 108, Issue:4

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Dabigatran; Hemorrhage; Humans; Hypertension; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Stroke

2022
Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2021, Volume: 49, Issue:8

    Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Myocardial Infarction; Product Surveillance, Postmarketing; Prospective Studies; Registries; Sex Factors; Stroke; Thromboembolism; Turkey

2021
Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs.
    International journal of environmental research and public health, 2022, 09-21, Volume: 19, Issue:19

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Hypertension; Male; Pyridones; Rivaroxaban; Stroke; Thromboembolism

2022
Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation Combined With Hypertension: A Multicenter, Retrospective Cohort Study.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:8

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Hypertension; Retrospective Studies; Rivaroxaban; Stroke; Thromboembolism; Warfarin

2023
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
    The American journal of medicine, 2020, Volume: 133, Issue:8

    Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries

2020
Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
    Clinical therapeutics, 2020, Volume: 42, Issue:9

    Topics: Administration, Intravenous; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Hypertension; Male; Renal Insufficiency, Chronic; Stroke; Thrombolytic Therapy

2020
Diastolic blood pressure achieved at target systolic blood pressure (120-140 mm Hg) and dabigatran-related bleeding in patients with nonvalvular atrial fibrillation: A real-world study.
    Anatolian journal of cardiology, 2020, Volume: 24, Issue:4

    Topics: Aged; Anticoagulants; Atrial Fibrillation; China; Dabigatran; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged

2020
[Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
    Voprosy virusologii, 2021, 03-07, Volume: 66, Issue:1

    Topics: Acetylcysteine; Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Atrial Fibrillation; Azithromycin; Cohort Studies; Comorbidity; Coronary Disease; COVID-19; COVID-19 Drug Treatment; Dabigatran; Disseminated Intravascular Coagulation; Female; Humans; Hypertension; Indoles; Interferon alpha-2; Intracranial Arteriosclerosis; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; SARS-CoV-2; Severity of Illness Index; Survival Analysis

2021
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
    The American journal of cardiology, 2021, 06-15, Volume: 149

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Body Mass Index; Coronary Disease; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Medication Adherence; Middle Aged; Polypharmacy; Proportional Hazards Models; Stroke; Warfarin

2021
    Acta medica Philippina, 2017, Volume: 51, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy

2017
Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice.
    International journal of molecular sciences, 2021, Aug-12, Volume: 22, Issue:16

    Topics: Angiotensin II; Animals; Antithrombins; Chromatography, Liquid; Dabigatran; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Intercellular Adhesion Molecule-1; Male; Mice; Nitric Oxide; Tandem Mass Spectrometry; Vascular Remodeling; von Willebrand Factor

2021
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Journal of medical case reports, 2017, Aug-15, Volume: 11, Issue:1

    Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Interactions; Female; Humans; Hypertension; Stroke; Thrombolytic Therapy; Treatment Outcome

2017
Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Germany; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Primary Health Care; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K

2017
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events.
    Critical pathways in cardiology, 2018, Volume: 17, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin

2018
Can dabigatran improve blood pressure control?
    Future cardiology, 2013, Volume: 9, Issue:3

    Topics: Acenocoumarol; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; Hypertension; Losartan; Male

2013
Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:3

    Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Complications; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin

2013
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6

    Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, Type 2; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency, Chronic; Thrombophilia; Urinary Tract Infections

2013
[Prevention and treatment of major bleeding during anticoagulation].
    Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11

    Topics: Administration, Oral; Alcohol Drinking; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Diabetes Mellitus; Drug Therapy, Combination; Factor IX; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Risk Assessment; Risk Factors; Smoking; Vitamin K; Warfarin

2013
Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: Case report with literature review.
    Acta anaesthesiologica Scandinavica, 2014, Volume: 58, Issue:5

    Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Valve Insufficiency; Atrial Fibrillation; Benzimidazoles; Blood Coagulation Factors; Blood Coagulation Tests; Blood Component Transfusion; Cardiac Tamponade; Cardiopulmonary Bypass; Dabigatran; Emergencies; Fatal Outcome; Heart Valve Prosthesis Implantation; Hemodiafiltration; Heparin; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Pyridines; Shock, Hemorrhagic; Thrombelastography; Tranexamic Acid

2014
[Exfoliative esophagitis while taking dabigatran].
    Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Endoscopy, Digestive System; Esophagitis; Female; Fluid Therapy; Humans; Hypertension; Pantoprazole

2015
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke, 2016, Volume: 47, Issue:7

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator

2016
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    American heart journal, 2016, Volume: 179

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin

2016